Details for New Drug Application (NDA): 208856
✉ Email this page to a colleague
The generic ingredient in CELECOXIB is celecoxib. There are twenty-six drug master file entries for this compound. Sixty-five suppliers are listed for this compound. Additional details are available on the celecoxib profile page.
Summary for 208856
Tradename: | CELECOXIB |
Applicant: | Qingdao Baheal Pharm |
Ingredient: | celecoxib |
Patents: | 0 |
Pharmacology for NDA: 208856
Mechanism of Action | Cyclooxygenase Inhibitors |
Medical Subject Heading (MeSH) Categories for 208856
Suppliers and Packaging for NDA: 208856
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CELECOXIB | celecoxib | CAPSULE;ORAL | 208856 | ANDA | Qingdao BAHEAL Pharmaceutical Co., Ltd. | 70247-006 | 70247-006-06 | 60 CAPSULE in 1 BOTTLE (70247-006-06) |
CELECOXIB | celecoxib | CAPSULE;ORAL | 208856 | ANDA | Qingdao BAHEAL Pharmaceutical Co., Ltd. | 70247-007 | 70247-007-10 | 100 CAPSULE in 1 BOTTLE (70247-007-10) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 50MG | ||||
Approval Date: | Aug 7, 2019 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 100MG | ||||
Approval Date: | Aug 7, 2019 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 200MG | ||||
Approval Date: | Aug 7, 2019 | TE: | AB | RLD: | No |
Complete Access Available with Subscription